US5128144A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Pressing having sustained release of active compound
Assignee: PCD Polymere GmbH
•
Filing: 1990-09-25
•
Granted: 1992-07-07
•
Expires: 2010-09-25
Abstract
Abstract Pressing having sustained release of active compound for the oral or parenteral administration of medicaments, which contains at least one solid pharmaceutical active compound, polylactic acid and a homo- or copolymer of D(-)-3-hydroxybutyric acid and processes for its production.
Inventors
- 👤 Brigitta Korsatko-Wabnegg
- 👤 Werner Korsatko
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-04 19:33
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/20; A61K9/2004; A61K9/2022; A61K9/2031; A61K9/204
Claims Analysis
Total Claims: 11
Claim 1
Independent Claim
72 words
A pharmaceutical composition for the oral or parenteral administration of medicaments in compressed form having sustained release of active compound comprising at least one solid pharmaceutically active compound, polylactic acid having a molecular weight of about 2,500 to 200,000 and a homo- or copolymer of D(-)-3-hydroxybutyric acid having a molecular weight of about 25,000 to 1,000,000, the polylactic acid: homo- or copolymer of D(-)-3-hydroxybutyric acid weight ratio being from 10:90 to 90:10.
Claim 2
Dependent Claim
72 words
A pharmaceutical composition for the oral or parenteral administration of medicaments in compressed form having sustained release of active compound comprising at least one solid pharmaceutically active compound, polylactic acid having a molecular weight of about 2,500 to 200,000 and a homo- or copolymer of D(-)-3-hydroxybutyric acid having a molecular weight of about 25,000 to 1,000,000, the polylactic acid: homo- or copolymer of D(-)-3-hydroxybutyric acid weight ratio being from 10:90 to 90:10.
Claim 3
Dependent Claim
18 words
The composition according to claim 1, wherein the polylactic acid has a molecular weight of 3,000 to 150,000.
Claim 4
Dependent Claim
22 words
The composition according to claim 1, wherein the homo- or copolymer of D(-)-3-hydroxybutyric acid has a molecular weight of 50,000 to 800,000.
Claim 5
Dependent Claim
27 words
The composition according to any one of claims 2, 3 and 4, wherein the composition contains 5 to 80 percent by weight of solid pharmaceutically active compound.
Claim 6
Dependent Claim
115 words
A process for the production of a pharmaceutical composition for the oral or parenteral administration of medicaments in compressed form having sustained release of active compound comprising combining and mixing at least one solid pharmaceutically active compound in solid, dissolved or suspended form with solid or dissolved polylactic acid having a molecular weight of about 2,500 to 200,000 and solid or dissolved homo- or copolymer of D(-)-3-hydroxybutyric acid having a molecular weight of about 25,000 to 1,000,000, the weight ratio of polylactic acid: homo- or copolymer of (D(-)-3-hydroxybutyric acid being from 10:90 to 90:10, evaporating the solvent or diluent which may be present and compressing the residue with or without drying and grinding before compressing.
Claim 7
Dependent Claim
115 words
A process for the production of a pharmaceutical composition for the oral or parenteral administration of medicaments in compressed form having sustained release of active compound comprising combining and mixing at least one solid pharmaceutically active compound in solid, dissolved or suspended form with solid or dissolved polylactic acid having a molecular weight of about 2,500 to 200,000 and solid or dissolved homo- or copolymer of D(-)-3-hydroxybutyric acid having a molecular weight of about 25,000 to 1,000,000, the weight ratio of polylactic acid: homo- or copolymer of (D(-)-3-hydroxybutyric acid being from 10:90 to 90:10, evaporating the solvent or diluent which may be present and compressing the residue with or without drying and grinding before compressing.
Claim 8
Dependent Claim
30 words
The process according to claim 5, comprising mixing and compressing at least one solid pharmaceutically active compound with solid polylactic acid and a solid homo- or copolymer of D(-)-3-hydroxybutyric acid.
Claim 9
Dependent Claim
39 words
The process according to claim 5, comprising spraying at lease one solid pharmaceutically active compound or granules thereof in a fluidized bed granulator with a solution of polylactic acid and homo- or copolymer of D(-)-3-hydroxybutyric acid, drying and compressing.
Claim 10
Dependent Claim
52 words
The process according to claim 5, comprising suspending at least one solid pharmaceutically active compound in a solvent for polylactic acid and for homo- or copolymer of D(-)-3-hydroxybutyric acid, mixing with dissolved polylactic acid and dissolved homo- or copolymer of D(-)-3-hydroxybutyric acid, evaporating the solvent, drying and grinding the residue and compressing.
Claim 11
Dependent Claim
53 words
The process according to claim 5, comprising dissolving at least one solid pharmaceutically active compound in a solvent for polylactic acid and for homo- or copolymer of D(-)-3-hydroxybutyric acid, adding and mixing dissolved polylactic acid and dissolved homo- or copolymer of D(-)-3-hydroxybutyric acid, evaporating the solvent, drying and grinding the residue and compressing.
References Cited (Backward Citations)
DE2051580A1
Cited
US3773919A
Cited
WO1978000011A1
Cited
EP0058481A1
Cited
EP0092918A2
Cited
EP0108882A1
Cited
US4491575A
Cited
EP0133988A2
Cited
US4786598A
Cited
DE3410380A1
Cited
EP0164571A2
Cited
DE3417576A1
Cited
AT383270B
Cited
EP0168862A2
Cited
EP0172412A2
Cited
EP0263490A2
Cited
DE3636209A1
Cited
DE3701625A1
Cited
DE3712095A1
Cited
US4902516A
Cited
US4859763A
Cited
GB2209937A
Cited
EP0315875A1
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1995-07-07 | 1996-01-06 | 1996-07-07 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1999-07-07 | 2000-01-06 | 2000-07-07 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2003-07-07 | 2004-01-06 | 2004-07-07 | $7700.00 | Window Closed / Lapsed |